| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| UNII | |
| Chemical and physical data | |
| Formula | C25H26N2O |
| Molar mass | 370.496 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE,SGT-273) is agamma-carboline basedsynthetic cannabinoid receptor agonist that has been sold as adesigner drug, first being identified in Hungary in April 2020.[1]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |